Royal Pharmaceutical Society of Great Britain, London
Friday 6 March 2009
09.55 Opening comments by the Chair
10.00 The MHRA strategy for bringing herbal medicine into effective regulation: what progress have we made? Richard Woodfield, MHRA
10.30 The regulatory maze - how to achieve success with your UK herbal registration application D. Middleton, BHMA/Schwabe
11.00 Quality of herbal medicinal products - a UK regulatory perspective during the first four years Linda Anderson, MHRA
11.30 “And now I have a registered product….” - Post-registration challenges from an industrial perspective, with a focus on pharmacovigilance, regular stability testing, GMP, post marketing surveillance Rainer Kolkman, Diapharm Regulatory Services, Germany
12.00 Lunch
13.00 Fitting old traditions into a new regulatory framework - experiences and outlook Werner Knoess, BfArM
13.30 Are ESCOP and European Pharmacopoeia monographs useful for developing new traditional herbal medicinal products (THMP)?Arnold Vlietinck, University of Antwerp, Belgium
14.30 Round table (bringing together stakeholders from regulators, industry and consumers)
Panel: Christine Gratus, Herbal Medicines Advisory Committee; Agnes Grunwald Spier, Herbal Medicines Advisory Committee; Linda Anderson, MHRA; Richard Woodfield, MHRA; Arnold Vlietinck, University of Antwerp; Jen Tan, A Vogel, Irvine; Sebastian Pole, Pukkaherbs; Victor Perfitt, Bio-Health
14.00 Coffee
14.30 Round table
16.30 Close of conference
|
|